Glendale, CA - (NewMediaWire) - April 15, 2021 - Loop Media, Inc. (“Loop Media”), a leading provider of its own branded music video and entertainment streaming services for businesses and consumers (OTC: LPTV), today announced a channel partnership to launch Doing Things Media channels on the Loop platform.The content partnership will bring Doing Things’ entertaining video content, which includes some of the most popular brands built on Instagram, YouTube and Snapchat to Loop’s Out of Home (OOH) clients. Doing Things’ library of 160K+ viral videos adds to Loop’s growing library of premium videos to further strengthen Loop’s offering and allow clients to use their Loop players to create and enhance their venue environment and customer experience. Doing Things Media owns and operates many of the Internet’s funniest meme properties, including: ● Middle Class Fancy - Suburban culture at its finest● Animals Doing Things - The funniest + cutest page for animal lovers● Doggos Doing Things - If a dog had a meme page● Rad Dad - Grade A dad content● Neat Mom - Thoughts by a millennial Mom“As our client location footprint grows rapidly, so does our need to satisfy the diverse collection of businesses we serve with content that enhances a customer’s visit. Doing Things Media is a leader in laughs and fun, and adding their massive collection of viral videos to Loop will be a great addition to our music video channels and other programming,” says Andy Schuon, Head of Loop Media Studios.“Doing Things Media’s video library is a perfect fit for bars and restaurants because the content is truly universal and intended to make people laugh,” says Derek Lucas, Co-Founder & Chief Creative Officer of Doing Things Media. “Our video content can be enjoyed by people of any language with or without audio. We’re excited to partner with Loop Media to bring this form of entertainment to audiences at restaurants, venues, bars, pet stores, retail and hospitality as the world begins to reopen.”About Loop MediaLoop Media, Inc. is a leading provider of video streaming services for businesses and consumers that features its own branded music and entertainment channels and curated playlists. Through its proprietary Loop Player for businesses and interactive mobile and TV apps for consumers, Loop Media is the only company in the U.S. licensed to stream music videos directly to consumers and venues out of home. Loop Media’s content reaches thousands of out-of-home (OOH) locations including hotels, bars/restaurants, office buildings, and retail businesses, as well as millions of consumers in the U.S., Canada, and Latin America through its apps for iOS, Android, and Huawei, as well as connected TVs and Smart TVs. To date, these include Amazon Fire TV, Android TV, AT&T TV, Hisense, JVC, LG, Philips, Roku, Sharp, Sony, Toshiba, VIZIO, and free ad-supported TV platforms TIVO+, Plex, DistroTV, and GSTV. One of the largest and most important libraries of music videos, live performances, and other content ever assembled fuels Loop Media channels in a multitude of genres and moods: non-music channels focused on movie trailers, sports highlights, lifestyle and travel, viral videos, and more. The Loop consumer apps allow users to create their own playlists or “Loops” and share them live with interactive watch parties. Loop Media’s streaming services generate revenue from advertising, sponsorships, integrated marketing, and branded content from free-ad-supported-television (FAST) and from subscription offerings.Download the Loop app by searching “Loop Media” on your Smart TV's app store or opening loop.tv/app on your mobile device. To learn more about Loop products and applications, please visit us online at Loop.tvFollow us on social:Instagram - @looptvofficial (consumer), @looptvbiz (business)Twitter - @looptvofficial (consumer), @looptvbiz (business)LinkedIn - https://www.linkedin.com/company/looptv/About Doing Things ...
New York, NY - (NewMediaWire) - April 15, 2021 - PCG Digital -- Hypertension, or high blood pressure, is known as the "silent killer" because it causes more than 7 million deaths each year-often with next to no symptoms. Hypertension puts people at greater risk for heart disease and stroke, the leading causes of death in the United States, according to the Centers for Disease Control. Nearly half of adults in the United States have high blood pressure or are currently taking medication for hypertension-and very few have it under control.Fortunately, there is good news on the horizon, as Lexaria Bioscience (Nasdaq: LEXX) aims to turn the tide on hypertension. While the three leading hypertension drugs available on the market can save lives, they also cause a lot of unwanted side effects-everything from headaches to nausea to dizziness to fatigue. Despite having already notched more than $100 billion in sales, these medications are problematic for many.Cannot view this video? Visit:https://www.youtube.com/watch?v=8m-vPilohPIDehydraTECH to revolutionize hypertension market That's where DehydraTECH CBD by Lexaria comes in. This revolutionary oral deliverable for hypertension sufferers is set to be a market game-changer with its potential for minimal side effects and maximum effectiveness. Using a patented dehydration process that changes how the body senses and absorbs drugs orally, DehydraTECH CBD has been shown to deliver 300% more CBD than generic CBD in less than 30 minutes. It is in human clinical trials right now with already promising results."Our 2018 human clinical trial showed that DehydraTECH CBD lowers blood pressure by about 5% after just a single 90 milligram dose," said Lexaria CEO Chris Bunka. "Generic CBD doesn't do that. Our objective in our new 2021 clinical studies is to evidence a 10% or greater drop in blood pressure to be competitive with industry demands."Lexaria believes it can evidence a 10 to 20% reduction in blood pressure in studies during the next six to nine months-the competitive standard for successful hypertension drugs. "In the hypertension industry, drugs that provide a 10 to 20 percent reduction in blood pressure are generally successful," Bunka adds. "We are confident we can get to that level and expect our studies to provide evidence supporting that this year." While the trials are in process, the company continues to examine smart ways to commercialize DehydraTECH CBD as a regulated form of CBD.Partnering for better health outcomesTo tap into the almost $30 billion hypertension market, Lexaria will look to partner with Big Pharma in delivering this potentially life-saving treatment. With animal trial results expected in May and human clinical results in September, as well as industry precedents that are already established, the path to commercialization is becoming clear.Likewise, with existing patents granted in the EU and Australia for the treatment of heart disease using cannabinoids, Lexaria is anticipated to achieve regulatory approvals in multiple geographic markets.All of this is great news for the many people across the globe who suffer from hypertension and for those seeking a better treatment alternative.DisclaimerThis communication was produced by PCG Digital Holdings, LLC, an affiliate of PCG Advisory Inc., (together "PCG"). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this may be 'Paid Advertising' for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the "Securities Act"). PCG may be compensated by respective clients for publicizing information relating to its client's securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.PCG is not a registered or licensed broker, dealer, broker-dealer, investment adviser ...
Burbank, CA - (NewMediaWire) - April 15, 2021 - Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that Quanta’s President and Director Philip Sands will be presenting virtually at a cannabis investing conference, the 2021 Sequire Cannabis Conference, on Tuesday, April 20, at 3 p.m. EST/12 p.m. PST.Sands will discuss how Medolife Rx and Quanta will continue to develop their positions in the bioceutical space. He will further discuss their cutting-edge technology, pharmaceutical research, and the development of consumer wellness products for the CBD industry. Additionally, he will address how the Company is planning to develop pharmaceutical-grade CBD products lines for which it will seek clinical regulatory approvals, focusing on indications such as pain.“Given his deep history with the Company and expertise on the cannabinoid-based product industry, I am excited to see Mr. Sands present on Medolife and Quanta at this conference,” said Medolife CEO Dr. Arthur Mikaelian. “Medolife and Quanta have had an exciting year, and we plan to use this opportunity to share how we believe we are well-positioned for growth and success in the future. “From capitalizing on our proprietary polarization delivery technology to facility expansions and ongoing sales of our numerous consumer wellness products, there are many opportunities on the horizon for our company and potential investors.”The Sequire Cannabis Conference is a one-day event that brings together a select group of U.S. investors and leading industry participants in the cannabis space. The event will feature video presentations from more than 15 companies, organized in five tracks for attendees.For those who cannot attend the live presentation, a video webcast of the presentation will be available. To learn more about the 2021 Squire Cannabis Conference and register to participate, visit https://cannabis-conference.mysequire.com/.About Medolife RxMedolife Rx, Inc. is a global biotechnology company with operations in clinical research, manufacturing, and consumer products. Medolife Rx was created through the merger of Medolife, a private company founded by Dr. Arthur Mikaelian who pioneered the unlaying polarization technology that makes the Company’s portfolio of pharmaceutical and nutraceutical products so effective, and Quanta, Inc., a direct-to-consumer wellness product portfolio company. The Company’s lead clinical development programs include Escozine®, a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princepsscorpions, which is amplified by the Company’s polarization technology and is being researched as a treatment of various indications, including COVID-19 and cancer. The Company has completed preclinical safety and efficacy research on Escozine® and is pursuing product registration and drug approval in various countries, including the United States and throughout Latin America. Through its subsidiary QuantRx, Medolife manufactures and distributes consumer wellness products in high-impact consumer areas such as pain relief, beauty, and general wellness. QuantRx products are designed using Dr. Mikaelian’s polarization technology, which applies advances in quantum biology to increase the potency of active ingredients. Ultimately, Quanta's mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste, and facilitate healthier, more sustainable consumption.Beyond its own clinical and consumer applications, the polarization technology used by Medolife and its subsidiaries has many potential applications. From potentiating bio-ingredients, to producing more-effective carbon-trapping plants, to transformative anti-aging solutions, Medolife has the opportunity to upend how commercial and pharmaceutical products are made and increase their benefits, while decreasing their chemical concentration.Forward-Looking StatementsSafe Harbor ...
--Acquisition Includes Revenue Producing Interests in the DJ Basin of Wyoming--Frisco, TX - (NewMediaWire) - April 15, 2021 - Verde Bio Holdings, Inc. (OTC: VBHI), a growing oil and gas Company, today announced that it continues to execute on its business plans of acquiring revenue producing property by adding mineral and royalty interests held by a private seller for a purchase price of $497,764 in cash. The interest acquired by Verde currently produces approximately $8,000 per month in revenue and Verde is entitled to the cash flow from production attributable to the acquisition beginning on or after April 1, 2021.As mentioned in our previous press releases, the Company continues to build a diversified, revenue producing portfolio of high-quality assets. The Company has holdings in Wyoming, Texas, Colorado, West Virginia, Louisiana and Oklahoma. Today’s announcement brings the total number of acquisitions to twelve for Verde to date. Current expected combined revenue from the acquisitions is approximately $46,000 per month or more than $450,000 on an annualized basis once the company is in pay status on all properties. The interest being acquired covers approximately 52 royalty acres in a 1600-acre drilling unit located in Laramie County, Wyoming and is operated by best-in-class EOG Resources. Currently, there are eight wells producing out of laterals ranging from 10,260 feet to 12,640 in stacked pay from the Niobrara and Codell formations. The transaction represents Verde’s fifth acquisition in the prolific DJ Basin.Scott Cox, CEO of Verde, said, “We are excited about the interests being acquired through this acquisition. This is a great oil producing addition to our portfolio and we are proud to have built a Company which is creative and flexible enough to take advantage of these deals which require an accelerated timeline for closing.” Mr. Cox added, “We have great confidence in these assets, as well as the DJ Basin as a whole, and we look forward to jointly benefiting as they continue to operate and develop the resource. EOG is a great operator, and we are pleased with what they are doing in this area with stacked pay production. We have high hopes for this property and its future.”“Deals like this continue to confirm our business plan of acquiring diversified minerals and royalties and building a portfolio while taking advantage of the historic buyer’s market in the industry currently. We remain focused on executing our business plan and creating long-term value for our shareholders. Through our balanced approach of capital raising and acquisitions, we have begun to build a highly diversified portfolio of revenue producing interests and look forward to continuing to build on these through future strategic acquisitions,” Mr. Cox concluded. About Verde Bio Holdings, Inc.Verde Bio Holdings, Inc. (OTC: VBHI), is a growing U.S. Energy Company based in Frisco, Texas, engaged in the acquisition and development of high-growth mineral rights and select non-operated working interests in premier U.S. basins. Verde currently owns producing mineral, royalty and over-riding royalty interests in the Denver-Julesburg Basin of Colorado and Wyoming, the Haynesville Shale of Louisiana, the Anadarko Basin of Oklahoma, the Delaware and Permian Basin of Texas and the Marcellus and Utica shales in West Virginia. The Company is focused on providing strong shareholder returns through asset growth generated by our acquisitions of revenue producing assets.Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:Statements in this press release that are not strictly historical are “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve a high degree of risk and uncertainty, are predictions only and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could cause or contribute to differences include the ...
Connecticut - (NewMediaWire) - April 15, 2021 - Avant Capital Partners (“Avant”), a leading private commercial real estate lender, has reached agreement to create a programmatic joint venture with a Connecticut based investment management platform with assets under management in excess of $10 billion (the “platform”). The platform is an active investor across several credit strategies, including real estate debt, and has tapped Avant to originate, underwrite, close and manage loan investments from $5 million to $75 million on a nationwide basis.Under Avant’s platform, the venture will originate bridge loans secured by property types that include multi-family, light industrial, warehouse, office and select hospitality and retail. The loan program is designed to finance properties that are being repositioned, newly constructed and in lease up phase, improved or otherwise redeveloped, or need a quick close. Each loan will be underwritten to a clear exit strategy thru conventional bank, agency or CMBS refinance for loan repayment. Additionally, the venture’s mandate allows Avant to acquire distressed commercial real estate debt.The venture will be complementary to Avant’s existing capital base which includes allocations from family offices, foundations, life insurance companies and several credit facilities. Since inception, Avant has made over 100 separate loan investments including newly originated bridge loans and the acquisition of non-performing loans."We are excited to announce this venture with such a reputable, and well capitalized, debt investment manager,” says Adam Luysterborghs, Managing Partner at Avant. He adds that, “This pool of capital will enable us to execute on larger deals and at lower interest rates than we previously offered. Importantly, all debt investments originated under this program will be held on balance sheet and there are no plans to securitize any of the loans.” Summary of terms:- Loan amounts: $5,000,000 to $75,000,000- Interest rates: LIBOR plus 450 to 750- Up to 75% LTV; up to 85% LTC on a select basis- One to three year terms- Properties located nationwide, including urban, suburban and rural markets- Property types: multifamily, industrial, office, hospitality & retail. Bernard Wolff, Avant’s portfolio manager responsible for the venture, says, “We are actively quoting deals and will announce our first series of closings soon. This new source of capital will significantly enhance Avant’s product offerings to the commercial real estate community and provide the flexibility to target deals backed by both performing and nonperforming loans nationwide.”About Avant Capital Partners – Avant Capital Partners is a Connecticut based real estate private equity firm thatcreates and manages investments in commercial real estate debt nationwide. The company has an origination presence in Connecticut, New York City, Beverly Hills, Chicago & Dallas and manages its portfolio of debt investments for the benefit of family office, foundation, high net worth and institutional investors.Bernard Wolff203-612-9581bernard@avant-capital.com
Tampa, FL - (NewMediaWire) - April 15, 2021 - B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to announce that the B2 Fighting Series is ready to rock the Macon Marriott City Center in Macon, Georgia, this Saturday, April 17, with another night of hard-hitting LIVE MMA action.What: B2 Fighting Series Macon, Amateur and Professional LIVE MMAWhere: Macon Marriott City Center in Macon, GAWhen: Saturday, April 17. Doors open at 6pm ET. PPV Broadcast starts at 7pm ET.In-person tickets for the event have nearly sold out, but interested fans can stream it live on Pay-Per-View here, or enjoy it live over the B2 Fighting Series apps on Amazon Fire TV or Apple TV.Brandon ‘Hardrock’ Higdon, B2’s Matchmaker, commented, “Atlanta's own Cole Ferrell has been mentioned as one of the top prospects for Dana White's Contender Series. A big win over Tim Eschtruth should get him that call. Team Alpha male fighter Carlos Figueroa makes the long flight from California to take on Macon’s top 135-pound pro fighter Chase Boutwell. Ten fights on this card – every one of them has me excited. Our first event in Georgia is shaping up as an epic night of mixed martial arts!”Saturday’s B2 Fighting Series card features a combination of ten amateur and professional bouts. The main event of the night will feature undefeated pro featherweight star, Cole Ferrell (10-0), as he takes on upset-minded veteran Judo blackbelt, Tim Eschtruth (5-3). The card will also feature two amateur title fights and an exciting pro 135-pound matchup as Carlos Figueroa, who dropped his opponent in a stunning first-round KO in his only bout last year, comes to town to take on local rising star Chase Boutwell, fresh off a third-round submission victory in October.“We love to come to a new town and leave our mark, and this will be our first event in Georgia since receiving our license earlier this year,” noted Greg P. Bell, Chairman & CEO of B2Digital. “We continue to see steady accelerating growth in live event revenues. Last week in Kokomo, we sold out in 40 hours and booked our highest PPV revenues at that venue ever. Pent-up demand is clearly a tailwind, but the real story is our increasingly effective crowdsourced social media marketing model. We look forward to another tremendous night of MMA action and a growing crowd of excited fans this weekend in Macon.”About B2Digital Inc.With extensive background in entertainment, television, video, and technology, B2Digital (OTC: BTDG) is now forging ahead and becoming a full-service live event sports company. Capitalizing on the combination of B2Digital CEO Greg P. Bell’s expertise and involvement with more than 40,000 live events over his career for major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated Premier Development League, Expand the B2 Official Training Facility Program Network and Continue the growth of the B2 Social Media Network for the multibillion-dollar mixed martial arts (“MMA”) industry.B2Digital intends to create and develop league champions that will move on to the MMA major leagues from the Company’s B2 Fighting Series brand. Each year, the top fighters will be invited to the annual B2 Fighting Series National Championship live event.B2Digital has developed and deployed the systems and technologies for the operation of the B2 Fighting Series, “B2FS”. This includes social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, FTV (Free to View), merchandise sales, brand management and financial control systems. B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks, and branding for the B2Digital companies.For more information about B2Digital, visit the Company’s website at www.b2digitalotc.com. B2Digital has a growing social media presence. Follow us on:Twitter: ...
Statement Highlights: Good oral hygiene and regular dental care are the most important ways to reduce risk of a heart infection called infective endocarditis caused by bacteria in the mouth. There are four categories of heart patients considered to be at highest risk for adverse outcomes from infective endocarditis, and only these patients are recommended to receive preventive antibiotic treatment prior to invasive dental procedures. American Heart Association guidelines issued in 2007 suggested not to use antibiotics before certain dental procedures. These recommendations resulted in a decrease in antibiotic use. Embargoed until 4 a.m. CT / 5 a.m. ET Thursday, April 15, 2021 - (NewMediaWire) - April 15, 2021 - DALLAS - Maintenance of good oral health is more important than use of antibiotics in dental procedures for some heart patients to prevent a heart infection caused by bacteria around the teeth, according to a new American Heart Association (AHA) scientific statement published today in the association’s flagship journal, Circulation. Infective endocarditis (IE), also called bacterial endocarditis, is a heart infection caused by bacteria that enter the bloodstream and settle in the heart lining, a heart valve or a blood vessel. It is uncommon, but people with heart valve disease or previous valve surgery, congenital heart disease or recurrent infective endocarditis have a greater risk of complications if they develop IE. Intravenous drug use also increases risk for IE. Viridans group streptococcal infective endocarditis (VGS IE) is caused by bacteria that collect in plaque on the tooth surface and cause inflammation and swelling of the gums. There’s been concern that certain dental procedures may increase the risk of developing VGS IE in vulnerable patients. The new guidance affirms previous recommendations that only four categories of heart patients should be prescribed antibiotics prior to certain dental procedures to prevent VGS IE due to their higher risk for complications from the infection: those with prosthetic heart valves or prosthetic material used for valve repair; those who have had a previous case of infective endocarditis; adults and children with congenital heart disease; or people who have undergone a heart transplant. “Scientific data since the 2007 AHA guidelines support the view that limited use of preventive antibiotics for dental procedures hasn’t increased cases of endocarditis and is an important step at combating antibiotic overuse in the population,” said Walter R. Wilson, M.D., chair of the statement writing group and a consultant for the Division of Infectious Diseases, Department of Internal Medicine at Mayo Clinic in Rochester, Minn. It has been over a decade since recommendations for preventing infective endocarditis were updated amid concerns of antibiotic resistance due to overprescribing. The American Heart Association’s 2007 guidelines, which presented the biggest shift in recommendations from the Association on the prevention of infective endocarditis in more than 50 years, more tightly defined which patients should receive preventive antibiotics before certain dental procedures to the four high-risk categories. This change resulted in about 90% fewer patients requiring antibiotics. The scientific statement writing group reviewed data on VGS IE since the 2007 guidelines to determine if the guidelines had been accepted and followed, whether cases of and mortality due to VGS IE have increased or decreased, and if the guidance might need to be adjusted. The writing committee reports their extensive review of related research found: There was good general awareness of the changes in the 2007 guidelines, however, adherence to the guidelines was variable. There was about a 20% overall reduction in prescribing preventive antibiotics among high-risk patients, a 64% decrease among moderate-risk patients, and a 52% decrease in those patients at low- or unknown-risk. In a survey of 5,500 dentists in the U.S., 70% reported prescribing preventive antibiotics to patients even though the ...
DALLAS, Texas - - (NewMediaWire) - April 15, 2021 - – Earlier this week, the Centers for Disease Control and Prevention (CDC) and the U.S. Food & Drug Administration (FDA) recommended a pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine because six women, ages 18-48 years, of the nearly 7 million adults who have received this vaccine experienced cerebral venous sinus thrombosis (CVST), or blood clots in the brain’s veins (not in the arteries, as is the case for most strokes). CVST is an extremely rare but serious type of stroke caused by a blood clot in a part of the brain known as the venous sinus, involving veins that carry blood away from the brain. Spontaneous CVST is estimated to affect 5 of every 1 million people in the world annually. It can cause serious disability or even death. In contrast, the vast majority of strokes (approximately 87% of nearly 800,000 strokes in the U.S. annually) are ischemic strokes – blood clots in the arteries that lead to interruption of nourishing blood flow to the brain. When should you worry that you may have CVST, or blood clotting elsewhere in the body, as compared to some of the typical symptoms after the COVID-19 vaccine, or compared to symptoms of an ischemic stroke? CVST and Other Blood Clot Symptoms (CVST occurs in the veins of the brain; if associated with vaccine, cases occurred several days to 2 weeks after being vaccinated; blood clots may also occur in other blood vessels, like those in the legs, lungs or abdomen) Severe headache Blurry vision or shortness of breath Fainting or loss of consciousness Weakness Sensory Changes Confusion or trouble speaking Seizures Abdominal pain Leg pain Difficulty breathing/shortness of breath Symptoms occur several days and up to 2 weeks after receiving the Johnson & Johnson (Janssen) COVID-19 vaccine. Call 911 to receive emergency medical care as soon as possible. Typical COVID-19 Vaccine Symptoms (usually within 24-48 hours of receiving the vaccine) Tiredness Headache Muscle pain Chills Fever Nausea Symptoms usually pass within 36-48 hours after receiving the vaccine. If symptoms are severe and include difficulty breathing, seek immediate medical attention – call 911 or go to the nearest emergency room. Ischemic Stroke Symptoms (occurs in the arteries that provide nourishing blood flow to the brain) Remember FAST: F=Face drooping A=Arm weakness S=Speech difficulty or slurred speech T=Time to call 911. If someone shows any of these symptoms, even if the symptoms go away, call 911 to receive emergency medical care as soon as possible. Check the time so you can tell emergency responders when the first symptoms appeared. Other symptoms may include sudden headache, vision changes, or sudden loss of balance. Not related to vaccine. About 1-2% of patients hospitalized with COVID-19 may experience ischemic strokes. The following statement reflects the views of the American Heart Association/American Stroke Association and its science leaders: President Mitchell S.V. Elkind, M.D., M.S., FAHA, FAAN, Immediate Past President Robert A. Harrington, M.D., FAHA, President-Elect Donald M. Lloyd-Jones, M.D., Sc.M., FAHA, Chief Science and Medical Officer Mariell Jessup, M.D., FAHA, and Chief Medical Officer for Prevention Eduardo Sanchez, M.D, M.P.H., FAAFP. “These recently reported CVST blood clots are very rare adverse events (less than one in one million), and the recommended pause in administration of the Johnson & Johnson (Janssen) vaccine confirms that ongoing monitoring and transparency in the vaccine process are working. The constant review promised by the CDC and FDA, as well as the commitment throughout the scientific and medical field to ensure the safety of the vaccines, remain firm. These events are so uncommon that they only appeared after clinical trials concluded, when millions of people had been vaccinated, unlike the thousands in the original vaccine trials. We await the findings and updated guidance from the CDC and FDA urgent review of CVST associated with the Johnson & Johnson (Janssen) COVID-19 ...
Denver, Colorado - (NewMediaWire) - April 14, 2021 - CBD Global Sciences Inc. (CSE: CBDN) (the "Company") would like to provide an update on the status of the filing of its annual financial statements, accompanying management’s discussion and analysis and related CEO and CFO certifications for the year ended December 31, 2020 (collectively, the "Annual Filings"). Due to the continued impact of COVID-19, and the logistical complications for its auditor to conduct the audit of certain operations, the Company anticipates the Annual Filings will be delayed beyond the required filing deadline: (i) under Parts 4 and 5 of National Instrument 51-102 – Continuous Disclosure Obligations and pursuant to National Instrument 52-109 – Certification of Disclosure in Issuer’s Annual and Interim Filings, being April 30, 2021 (the "Filing Deadline").The Company intends to continue to work diligently and expeditiously with its auditors and expects to file the Annual Filings as soon as possible, and in any event no later than June 15, 2021.Other than as previously disclosed by the Company and herein with this press release, the Company confirms that there have been no material business developments since the date of its last financial statements that were filed.Management Cease Trade Order ApplicationIn light of the delay in filing of the Annual Filings prior to the Filing Deadline, the Company is providing this default announcement in accordance with National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). The Company has made an application to the Alberta Securities Commission (the "ASC"), as principal regulator of the Company, for a management cease trade order ("MCTO") under NP 12-203 in respect of the anticipated default regarding the Annual Filings. The granting of the MCTO is at the discretion of the Alberta Securities Commission and there is no guarantee that this will be granted. The issuance of the MCTO will not affect the ability of persons who have not been directors, officers, or insiders of the Company to trade in their securities. In the event that the MCTO is granted, it will be in effect until the default is remedied. The Company intends to follow the provisions of the Alternative Information Guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases, for as long as the Company remains in default.ABOUT CBD GLOBAL SCIENCES INC.CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals and CBD hydration products. CBD Global’s hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.CBD Global Sciences, through its wholly owned subsidiary, Strasburg Pharms, grows and operates irrigated land in Colorado that grows hemp with only all-natural Colorado water, soil, sun, and nutrients that is NEVER sprayed with pesticides or chemicals. Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD.For further information, please contact, Investor Relations, (888) 401-2239, info@cbdglobalsciences.com.NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may ...
Houston, TX - (NewMediaWire) - April 14, 2021 - PickleJar Holdings, an emerging peer-to-peer cashless tipping platform for artists and content creators, announces that the PickleJar™ iOS app will be featured as part of the “Randy Rogers and Wade Bowen: Hold My Beer & Watch This” acoustic performance on May 28, 2021. The event will be hosted at Mo’s Place in Katy, Texas with PickleJar proceeds and donations to benefit SOC-F, a Special Operations Veterans non-profit organization.“As we help modernize the music industry to create incredible in-person events and mobile experiences, we also believe it is just as important to use the technology of PickleJar to benefit those in need,” said Jeff James, PickleJar chairman and chief executive officer. “A special thank you to Mo’s Place for partnering with us to bring this event to life. Mo’s relentless support of up-and-coming artists for over 33 years has been an inspiration to the PickleJar team.”The PickleJar app was designed to create a better connection and experience between musicians, fans and organizations during in-person and livestreaming events by making the “giving back” process easier for everyone. In the weeks leading up to Memorial Day weekend, the app will be available for free download to the public.During the “Hold My Beer & Watch This” event, fans will be able to send tips and donations directly to the performers and the SOC-F organization during the show. Additionally, participants will be entered to win prizes and merchandise to be given away on-premises during the event.“We are proud to once again partner with PickleJar to host another fun and engaging event. They’ve continued to provide great ways for us to give back to our local community,” said Mo, owner of Mo’s Place. “For 33 years, we have served the Houston area and we want to show our appreciation by giving back this Memorial Day weekend and honoring those who have served our country.”To learn more about the PickleJar app, including pre-registering your handle, check out: https://picklejar.com/join-now/For more information about the “Hold My Beer & Watch This” acoustic performance event, including buying tickets, prize information and more, visit: https://bit.ly/3g4mKO0About PickleJar Holdings:PickleJar believes artists should have full control over the profitability of their creative talents. Our peer-to-peer payment technology and proprietary performance management tools make it frictionless to receive, manage and move money for musicians, content creators and artists of all kinds on any stage, streaming platform or street corner. Leveraging the deep fintech and music industry expertise of our leadership team, we have launched the first social payments app specifically built to put the #ArtistFirst. The cashless tipping app creates direct engagement between artists and fan, then tokenizes loyalty through a unique rewards program. We are committed to empowering people to maximize their earning potential and realizing their financial freedom in the new Gratitude Economy. Learn more about the “world’s biggest tip jar” at PickleJar.com.About Mo’s Place:Located in Katy, Texas, Mo’s Place is celebrating its 33rd Anniversary this year as “the place” that brings you the very best in live music and entertainment. Superstars such as Blake Shelton, Erich Church and Luke Bryan got their start on the Mo’s Place stage. In addition to our concerts, we provide nightly entertainment and events, a full dining experience and great drink specials. For more information, please visit: MosPlaceKaty.com. About SOC-F: Special Operations Care Fund was created in 2013 with one purpose: to make a positive and meaningful difference in the lives of the Special Operations Forces (SOF) families who have given so much for our country and our freedom. SOC-F does this by raising money for one incredibly worthwhile purpose: to provide medical, financial and other support to SOF members and their families in ways that are often not met through other sources – what they call the “gaps”. 100% volunteer run and led, the team at SOC-F ...
